| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/21/2014 | CN103800305A 一种α-Hed-GC-CD147纳米粒及其制备方法、应用、制剂 One kind of α-Hed-GC-CD147 nanoparticles and preparation methods, application, formulation |
| 05/21/2014 | CN103087994B 一种柯萨奇病毒a16型病毒株及其应用 One kind of coxsackievirus a16-type strain and its application |
| 05/21/2014 | CN103055311B 一种传染性喉气管炎粘膜疫苗及其制备方法和应用 An infectious laryngotracheitis mucosal vaccine and its preparation method and application |
| 05/21/2014 | CN102836427B 一种鸭病毒性肝炎免疫刺激复合物及其制备方法 One kind of duck hepatitis immunostimulatory compound and preparation method |
| 05/21/2014 | CN102816221B 鸡柔嫩艾美耳球虫ma1基因、载体、重组菌株和蛋白及其应用 Chicken Eimeria ma1 genes, vectors, recombinant strains and proteins and its application |
| 05/21/2014 | CN102805864B 鸡新城疫和h9n2亚型禽流感二联灭活疫苗及其制备方法 Newcastle disease and avian influenza subtype h9n2 bivalent inactivated vaccine and its preparation method |
| 05/21/2014 | CN102220289B 病毒的细胞许可因子及其用途 License factor virus cells and their use |
| 05/21/2014 | CN102216333B c-Met抗体 c-Met Antibodies |
| 05/21/2014 | CN102112135B 包含合成佐剂的疫苗组合物 Comprising a synthetic adjuvant vaccine composition |
| 05/21/2014 | CN101888878B 新型抗体 The new antibody |
| 05/21/2014 | CN101675992B β-淀粉样蛋白-类似物-T-细胞表位疫苗 β- amyloid - like -T- cell epitope vaccine |
| 05/20/2014 | US8729337 Production of polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
| 05/20/2014 | US8729234 Method for simultaneously detecting an antigen of, and an antibody, against, an infectious microorganism |
| 05/20/2014 | US8729231 Surface antigen protein mutant of hepatitis B virus surface antigen |
| 05/20/2014 | US8729039 Use of inhibitory oligonucleotides to treat autoimmune disease |
| 05/20/2014 | US8729031 Compounds |
| 05/20/2014 | US8728806 Methods and compositions related to Th-1 dendritic cells |
| 05/20/2014 | US8728796 Tiacumicin production |
| 05/20/2014 | US8728793 Amphipathic alpha-helical peptide compositions as antiviral agents |
| 05/20/2014 | US8728761 Production of glycosylated polypeptides in micro algae |
| 05/20/2014 | US8728747 Alteration of cell membrane for new functions |
| 05/20/2014 | US8728539 Method of enhancing intestinal pinocytosis of immunoglobulins in postnatal domestic mammals |
| 05/20/2014 | US8728523 Transdiscal administration of specific inhibitors of pro-inflammatory cytokines |
| 05/20/2014 | US8728515 Adjuvants for use in vaccination |
| 05/20/2014 | US8728492 Malaria vaccine compositions and constituents which elicit cell mediated immunity |
| 05/20/2014 | US8728491 Transcutaneous delivery of therapeutic agents |
| 05/20/2014 | US8728490 Streptococcus suis vaccines and diagnostic tests |
| 05/20/2014 | US8728489 Immunotherapy for chronic hepatitis C virus infection |
| 05/20/2014 | US8728488 Methods of inducing an immune response in a host by administering flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens |
| 05/20/2014 | US8728487 Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome |
| 05/20/2014 | US8728486 Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds |
| 05/20/2014 | US8728485 Peptide library obtained from multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome |
| 05/20/2014 | US8728484 Vaccine for runting-stunting syndrome |
| 05/20/2014 | US8728482 Humanized antibodies against TL1A |
| 05/20/2014 | US8728481 Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) |
| 05/20/2014 | US8728480 Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof |
| 05/20/2014 | US8728479 Antigen-binding proteins comprising recombinant protein scaffolds |
| 05/20/2014 | US8728478 Immunogenic Escherichia coli heat stable enterotoxin |
| 05/20/2014 | US8728477 Nucleotide and protein sequences of an antibody directed against an epitope common to human acidic and basic ferritins, monoclonal antibodies or antibody-like molecules comprising these sequences and uses thereof |
| 05/20/2014 | US8728475 Methods for treating inflammatory bowel disease |
| 05/20/2014 | US8728474 Immunopotentiative composition |
| 05/20/2014 | US8728473 Methods of preventing or treating pain using anti-NGF antibodies |
| 05/20/2014 | US8728471 Antibody therapy for treatment of diseases associated with gluten intolerance |
| 05/20/2014 | US8728470 CAB molecules |
| 05/20/2014 | US8728469 Method of treating rheumatoid arthritis using anti-IL-20 antibodies |
| 05/20/2014 | US8728468 Treatments for cancer |
| 05/20/2014 | US8728465 Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors |
| 05/20/2014 | US8728456 Programming of cells for tolerogenic therapies |
| 05/20/2014 | US8728438 Coronin 1 modulators for the treatment of autoimmune and lymphoproliferative disorders and mycobacterial infections |
| 05/20/2014 | CA2631938C Anti-il-17 antibodies |
| 05/20/2014 | CA2604538C Hiv vaccine |
| 05/20/2014 | CA2570458C Antibodies for selective apoptosis of cells |
| 05/20/2014 | CA2544853C Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases, and organ transplant rejection |
| 05/20/2014 | CA2364160C Product and method for treatment of conditions associated with receptor-desensitization |
| 05/15/2014 | WO2014075047A2 Malaria antigens and methods of use |
| 05/15/2014 | WO2014075033A2 Protein stabilizing factors |
| 05/15/2014 | WO2014074927A1 Methods of identifying, preventing, and treating virulent aleutian mink disease virus using replikin sequences |
| 05/15/2014 | WO2014074912A1 Compositions, methods and uses for dengue virus serotype-4 constructs |
| 05/15/2014 | WO2014074852A1 Compositions and methods for modulating an immune response |
| 05/15/2014 | WO2014074846A1 Methods for the treatment of bone loss |
| 05/15/2014 | WO2014074797A1 Ultra low density pulmonary powders |
| 05/15/2014 | WO2014074540A2 Antibodies to s. aureus surface determinants |
| 05/15/2014 | WO2014074535A2 Flavivirus envelope protein mutations affecting virion disassembly |
| 05/15/2014 | WO2014074532A2 Compositions and methods for modulating cell signaling |
| 05/15/2014 | WO2014074528A2 Combination therapies using anti-pseudomonas psl and pcrv binding molecules |
| 05/15/2014 | WO2014074470A1 Methods of treating s. aureus-associated diseases |
| 05/15/2014 | WO2014074230A1 Use of membrane vesicle-based vaccine against m. tuberculosis |
| 05/15/2014 | WO2014074218A1 Compounds and methods for producing a conjugate |
| 05/15/2014 | WO2014073845A1 A composition for treating diabetes or diabesity comprising oxyntomodulin analog |
| 05/15/2014 | WO2014073842A1 Liquid formulation of protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment |
| 05/15/2014 | WO2014073755A1 Adjuvant for influenza vaccine |
| 05/15/2014 | WO2014073641A1 Antibody capable of specifically recognizing transferrin receptor |
| 05/15/2014 | WO2014073529A1 MEDICINE COMPRISING MODULATOR OF ACTIVITY OF CD300a-EXPRESSING CELL ASSOCIATED WITH ALLERGIC DISEASE, CD300a GENE KNOCK-OUT MOUSE, AND USE OF MODULATOR OF ACTIVITY OF CD300a-EXPRESSING CELL |
| 05/15/2014 | WO2014073292A1 Anti-adam28 antibody for treating cancer |
| 05/15/2014 | WO2014072958A1 Peptides |
| 05/15/2014 | WO2014072876A1 Platelet-derived growth factor b specific antibodies and compositions and uses thereof |
| 05/15/2014 | WO2014072741A1 Humanised antibody and method of production thereof |
| 05/15/2014 | WO2014072405A1 Production of recombinant vaccine in e. coli by enzymatic conjugation |
| 05/15/2014 | WO2014072305A1 Anti-her3/her4 antigen binding proteins binding to the beta-hairpin of her3 and the beta-hairpin of her4 |
| 05/15/2014 | WO2014072277A1 Formulation for bispecific t-cell engagers (bites) |
| 05/15/2014 | WO2014072233A1 Novel immunoproteases |
| 05/15/2014 | WO2014071670A1 Use of human sdr5 protein or sdr5-fc antibody fusion protein as medicine for treating myocardial infarction |
| 05/15/2014 | WO2014023957A3 Anti-tumour response to modified self-epitopes |
| 05/15/2014 | WO2013177101A3 Il-17a/f il-23 bispecific antibodies and their uses |
| 05/15/2014 | WO2013040254A3 Anti-c.difficile toxin antibodies and associated methods |
| 05/15/2014 | WO2013040015A3 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 05/15/2014 | WO2013036795A3 Oncolytic herpes simplex virus and therapeutic uses thereof |
| 05/15/2014 | WO2013025467A3 Methods of treating hematological proliferative disorders by targeting epha3 expressed on aberrant vasculature in bone marrow |
| 05/15/2014 | WO2012174338A3 Method of selecting therapeutic indications |
| 05/15/2014 | US20140135487 Immunostimulatory g, u-containing oligoribonucleotides |
| 05/15/2014 | US20140135481 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 05/15/2014 | US20140135384 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 05/15/2014 | US20140135230 Lipoparticles Comprising Proteins, Methods Of Making, And Using The Same |
| 05/15/2014 | US20140134703 Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt |
| 05/15/2014 | US20140134257 Methods of treating melanoma |
| 05/15/2014 | US20140134209 Method for producing vaccinal viral strain of a virus of the reoviridae family |
| 05/15/2014 | US20140134208 Multi plasmid system for the production of influenza virus |
| 05/15/2014 | US20140134207 Recombinant rift valley fever (rvf) viruses and methods of use |
| 05/15/2014 | US20140134206 Inflammation and immunity treatments |
| 05/15/2014 | US20140134205 Compositions, methods and uses for dengue virus serotype-4 constructs |